We address the needs of thousands of patients
Grifols strives to generate long-term sustainable value for all of its stakeholder groups, with a clear emphasis on patients and donors, whose generosity makes our plasma-derived therapies possible.
Therapeutic areas
6
Treatments
Plasma and non-plasma therapies
Diagnostic solutions
Transfusional and Clinical
Immunology and Neurology
Immunodeficiencies and autoimmune disorders
Pulmonology
Alpha-1 antitrypsin deficiency
Hematology
Hemophilia and other bleeding and clotting disorders
Hepatology / Intensive Care
Hypovolemia and hypoalbuminemia in liver diseases, cardiac surgery, severe infection and other conditions.
